Faculty Member, Biodesign Center for Innovations in Medicine
School Director and Professor, School of Molecular Sciences
Chief Science Officer, Knowledge Enterprise
Neal Woodbury is Interim Executive Vice President and Chief Science and Technology Officer for ASU’s Knowledge Enterprise. In this capacity, he advances ASU’s research, economic development, international development and corporate engagement and strategic partnership agendas, as well as oversees activities related to KE operations, institutes and initiatives. Woodbury also promotes KE’s “Tier Three” initiatives aimed at identifying and pursuing high-level research opportunities.
Throughout the course of his 32-year tenure with ASU, Woodbury has been a trusted resource and advocate for ASU’s research enterprise, regularly advising ASU leadership on issues related to the university’s major research activities. He has been responsible for developing new, large-scale collaborative projects, as well as facilitating broad interactions between the Knowledge Enterprise and ASU’s academic units.
Woodbury is concurrently a senior sustainability scientist with the Julie Ann Wrigley Global Institute of Sustainability, and a faculty member in the Biodesign Center for Innovations in Medicine, the School of Molecular Sciences and GSI. He previously served as deputy director of the Biodesign Institute, and has a well-earned reputation as an astute and engaged leader. Woodbury is also CEO of Science Foundation of Arizona, a role in which he helps advance the goals of SFAz as a force for promoting science, high-tech industry and STEM education across Arizona.
An esteemed researcher, Woodbury has published more than 165 scientific works. He is an expert in the field of electron transfer and photosynthesis, and expanded his vast research repertoire as a human disease detective, co-founding HealthTell with ASU Professor Stephen Johnston. HealthTell focused on a diagnostic technology known as immunosignaturing, which involves fabrication of large numbers of peptides or related heteropolymers on silicon wafers. The resulting peptide arrays are the basis of a diagnostic platform that generates a comprehensive profile of circulating antibodies.
In addition to his academic and research achievements, Woodbury is a senior member of the National Academy of Inventors and holds multiple patents, including four which are licensed, one optioned and several pending. He completed his PhD in biochemistry at the University of Washington and holds a bachelor’s degree in biochemistry from the University of California at Davis.